Post
More of the same, sold as more
14 August 2026
More of the same, sold as more
Overselling in healthcare is almost never a character failure. It is an architecture failure. I have yet to meet a clinician who set out to recommend a scan a patient did not need. But place that clinician inside a system where revenue is earned per item, where the monthly target is assembled from procedure volume, where commercial performance is measured on average transaction value, and where nothing anywhere in the model rewards the sentence "you do not need this," and the outcome is not a surprise. It is the design working exactly as built.
So I stopped asking why clinics oversell. The more useful question, and the one I have to answer as the person who builds these systems, is: what did we construct that made overselling the rational choice?
In my experience it comes down to three things.
1. Revenue modelled on transactions rather than relationships, which leaves the team with one lever: add another line.
2. Clinical recommendation and commercial conversion collapsed into the same conversation, with no structural separation between the person advising and the person selling.
3. And no one has ever priced the cost of the unnecessary test: the patient who quietly does not rebook, the referral that never arrives, the trust that took eighteen months to build and one invoice to spend.
I do not think restraint is the softer commercial position. I think it is the harder one to build and the stronger one to own. That means modelling revenue on retention and lifetime value rather than visit yield. Separating clinical judgment from commercial conversion so that restraint is structurally possible, not just morally admirable. Measuring what was appropriately declined alongside what was sold. Designing programmes where the patient's outcome and the clinic's revenue move in the same direction, because if they move against each other, someone eventually loses, and it is usually the patient first and the clinic second.
Patients know the difference between being cared for and being converted. They can feel it before they can articulate it, and they pay accordingly.
Trust compounds. Transactions do not.
A clinic assessment is where I look for that restraint in an existing clinic. Investors should ask for the same test through operational due diligence.
